Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adverse cutaneous drug eruptions: current understanding.

Seminars in immunopathology - 1 Jan 2016

Hoetzenecker W, Nägeli M, Mehra E T, Jensen A N, Saulite I, Schmid-Grendelmeier P, Guenova E, Cozzio A, French L E

Abstract excerpt

Adverse cutaneous drug reactions are recognized as being major health problems worldwide causing considerable costs for health care systems. Most adverse cutaneous drug reactions follow a benign course; however, up to 2% of all adverse cutaneous drug eruptions are severe and life-threatening. These include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Eruptions

Share to Phenotype

Share to Stevens-Johnson Syndrome

Source

Identifiers

PMID: 26553194
DOI: 10.1007/s00281-015-0540-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adverse cutaneous drug eruptions: current understanding.PMID 26553194Read ↗

Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.Semantic proximity Read ↗

Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management.Semantic proximity Read ↗

Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Semantic proximity Read ↗

Epidemiology of severe drug hypersensitivity.Semantic proximity Read ↗

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read ↗

Advances in Prognostic Biomarkers and Targeted Immunomodulation in Severe Cutaneous Adverse ReactionsSemantic proximity Read ↗

Severe Cutaneous Adverse Drug Reactions: From Causes to MechanismsSemantic proximity Read ↗

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.Semantic proximity Read ↗

Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management.Semantic proximity Read ↗

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis- An OverviewSemantic proximity Read ↗

Toxic epidermal necrolysis and Stevens-Johnson syndrome.Semantic proximity Read ↗

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.